Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
BCAX
IART
Add up to 3 more stocks
BCAX
Bicara Therapeutics Inc. Common Stock
-4.22%
$16.56-0.73Delayed quote: Oct 6, 2026, 4:00 PM EDT
Market Cap
$1.09B
52W Range
$13.70 - $30.99
IART
Integra LifeSciences Holdings Corporation
+0.23%
$13.32+0.03Delayed quote: Oct 6, 2026, 4:00 PM EDT
Market Cap
$1.04B
52W Range
$8.70 - $20.49
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | N/A | N/A |
| Forward P/E | N/A | 5.46 |
| PEG Ratio | N/A | N/A |
| P/B Ratio | 2.32 | 0.99 |
| P/S Ratio | N/A | 0.63 |
| P/FCF Ratio | N/A | N/A |
| EV/EBITDA | N/A | 3.54 |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 0.0% | 53.7% |
| Operating Margin | 0.0% | 4.2% |
| Net Margin | 0.0% | -0.4% |
| ROE | -39.5% | -0.7% |
| ROA | -36.2% | -0.2% |
| ROIC | -43.0% | 20.0% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 11.59 | 3.40 |
| Quick Ratio | 11.59 | 1.98 |
| Debt/Equity | 0.00 | 1.94 |
| Interest Coverage | N/A | 0.79 |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | N/A | N/A |
| Payout Ratio | N/A | N/A |
| Yrs of Dividend Growth | 0 | 0 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.